Sandra Almeida, PhD, research assistant professor of neurology, has received an Alzheimer’s Association New Investigator Research Grant to study how variations in a gene along a specific neural pathway increase the risk of developing Alzheimer’s disease and frontotemporal dementia.
In a study published in the online biomedical sciences journal eLife, Oliver J. Rando, MD, PhD, and colleagues demonstrate that mice born of fathers who are habitually exposed to nicotine inherit enhanced chemical tolerance and drug clearance abilities.
A study by Benjamin U. Nwosu, MD, found an unexpectedly high incidence of vitamin D deficiency in children and adolescents with irritable bowel syndrome. The new findings point to monitoring and supplementing vitamin D in children with the disorder.
President Trump’s executive order on immigration is hurting America’s medical and science communities, jeopardizing the ability of foreign-born scientists, physicians and students to study and work here, according to an editorial by Chancellor Michael F. Collins published in STAT.
UMass Medical School ranked 29th out of 139 U.S. medical schools in National Institutes of Health funding, according to the 2016 report from the Blue Ridge Institute for Medical Research. Ten academic departments at UMMS ranked in the top 50 among their peers at other U.S. medical schools.
Jill A. Zitzewitz, PhD, associate professor of biochemistry & molecular pharmacology, is working to decipher the molecular basis of protein misfolding diseases, such as ALS and Alzheimer’s. Hear more about her research and mentoring in this Women in Science video.
A new study by UMass Medical School primary care experts finds videos help patients make informed decisions about controversial breast and prostate cancer screening recommendations.
Shlomit Schaal, MD, PhD, professor and chair ophthalmology, featured in the latest Women in Science video, studies diabetic retinopathy disease.
A worsening shortage of the antitoxin used to treat diphtheria, the deaths of two unvaccinated children to the disease in Europe and declining vaccination rates demonstrate the need for a new approach, and MassBiologics of UMass Medical School is developing one, according to a Jan. 13 story in the journal Science.
The groundbreaking technology called chromosome conformation capture, developed by Job Dekker, PhD, is being used to understand how errors in DNA organization inside cells lead to disease and illness, according to a Jan. 10 article in the New York Times.